Anti-MANEA monoclonal antibody

Pre-made anti-MANEA monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MANEA/MANEA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1146-Ab-1/ GM-Tg-hg-IP1146-Ab-2Anti-Human MANEA monoclonal antibodyHuman
GM-Tg-rg-IP1146-Ab-1/ GM-Tg-rg-IP1146-Ab-2Anti-Rat MANEA monoclonal antibodyRat
GM-Tg-mg-IP1146-Ab-1/ GM-Tg-mg-IP1146-Ab-2Anti-Mouse MANEA monoclonal antibodyMouse
GM-Tg-cynog-IP1146-Ab-1/ GM-Tg-cynog-IP1146-Ab-2Anti-Cynomolgus/ Rhesus macaque MANEA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1146-Ab-1/ GM-Tg-felg-IP1146-Ab-2Anti-Feline MANEA monoclonal antibodyFeline
GM-Tg-cang-IP1146-Ab-1/ GM-Tg-cang-IP1146-Ab-2Anti-Canine MANEA monoclonal antibodyCanine
GM-Tg-bovg-IP1146-Ab-1/ GM-Tg-bovg-IP1146-Ab-2Anti-Bovine MANEA monoclonal antibodyBovine
GM-Tg-equg-IP1146-Ab-1/ GM-Tg-equg-IP1146-Ab-2Anti-Equine MANEA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1146-Ab-1/ GM-Tg-hg-IP1146-Ab-2; GM-Tg-rg-IP1146-Ab-1/ GM-Tg-rg-IP1146-Ab-2;
GM-Tg-mg-IP1146-Ab-1/ GM-Tg-mg-IP1146-Ab-2; GM-Tg-cynog-IP1146-Ab-1/ GM-Tg-cynog-IP1146-Ab-2;
GM-Tg-felg-IP1146-Ab-1/ GM-Tg-felg-IP1146-Ab-2; GM-Tg-cang-IP1146-Ab-1/ GM-Tg-cang-IP1146-Ab-2;
GM-Tg-bovg-IP1146-Ab-1/ GM-Tg-bovg-IP1146-Ab-2; GM-Tg-equg-IP1146-Ab-1/ GM-Tg-equg-IP1146-Ab-2
Products NameAnti-MANEA monoclonal antibody
Formatmab
Target NameMANEA
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MANEA monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1146-Ag-1Recombinant multi-species MANEA/ ENDO/ hEndo protein
    ORF Viral VectorvGMLP001686human MANEA Lentivirus particle
    ORF Viral VectorpGMLP001686human MANEA Lentivirus plasmid
    ORF Viral VectorpGMLPm002664mouse Manea Lentivirus plasmid
    ORF Viral VectorvGMLPm002664mouse Manea Lentivirus particle


    Target information

    Target IDGM-IP1146
    Target NameMANEA
    Gene ID79694,242362,140808,708164,481925,101101567,512853,100065922
    Gene Symbol and Synonyms4932703L02Rik,ENDO,Enman,hEndo,MANEA
    Uniprot AccessionQ5SRI9,Q5GF25
    Uniprot Entry NameMANEA_HUMAN,MANEA_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172469
    Target ClassificationN/A

    The target: MANEA, gene name: MANEA, also named as ENDO, hEndo. N-glycosylation of proteins is initiated in the endoplasmic reticulum (ER) by the transfer of the preassembled oligosaccharide glucose-3-mannose-9-N-acetylglucosamine-2 from dolichyl pyrophosphate to acceptor sites on the target protein by an oligosaccharyltransferase complex. This core oligosaccharide is sequentially processed by several ER glycosidases and by an endomannosidase (E.C. 3.2.1.130), such as MANEA, in the Golgi. MANEA catalyzes the release of mono-, di-, and triglucosylmannose oligosaccharides by cleaving the alpha-1,2-mannosidic bond that links them to high-mannose glycans (Hamilton et al., 2005 [PubMed 15677381]).[supplied by OMIM, Sep 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.